https://www.selleckchem.com/products/cytidine.html
Higher stratified A1c levels were associated with increasing mean episode-of-care costs (6.5% to 6.9% = $18,912; 7.0% to 7.49% = $19,832; 7.5% to 7.9% = $20,827; 8% = $21,169). In multivariate analysis, patients with hemoglobin A1c 7.5% had higher episode-of-care costs ($2,331, 95% confidence interval, $511-$4,151, P = 0.012). Those with a hemoglobin A1c 7.5% had increased rates of complications (7% vs 3%, P = 0.049) and readmissions (11% vs 5%, P = 0.02. Hemoglobin A1c levels above 7.5% are associated with increased epis
Like
Comment
Share
